Approval is not the market.
Revenue is.
A UAE licence does not sell a device. A distributor with no offtake does not either. UAE Health Pathway is how 360Disruption runs healthcare files: classify, enable, find a commercial path — then talk about plant.
Why health files stall
Registered is not launched
MoHAP or EDE paper without a buyer, a channel and a responsible person is a folder.
One importer is not a market
Exclusive paper with no pull-through chokes the US company and teaches the UAE nothing.
Plant before proof
Cleanrooms follow classification, demand and ICV logic. They do not create them.
We do not award sites
Hospitals and investigators are candidates after qualification. 360FutureHealth does not assign trials.
The pathway
Classify
What the product actually is under UAE rules. Gaps in evidence and claims.
Enable
EDE / MoHAP / DHA path. Structure. Who can hold the file.
Activate
Pharmacy and retail where it fits — including Zaitoona for selected SKUs. Clinical only when the asset requires it.
Localize
Presence, assembly, manufacturing — if the file earns it.
Same Services-Led FDI rule. Healthcare modules only. One desk owns the file.
Who this is for
Manufacturers and rights holders
Diagnostics, devices, specialty pharma, oral formats, consumer health. Not individual clinicians seeking a job or a licence to practice.
A company that will sit in Discovery
AED 15,000 to see whether a UAE case exists. AED 50,000 to run activation. No nine-figure price until ownership, status and rights are on one page.
Start
Write to pathway@360disruption.com. Product, classification at home, what you want from the UAE in twelve months, what rights are free for GCC.
360FutureHealth is the healthcare interface. 360Disruption is the desk.
Healthcare files. Same engine. Different modules.